Logo

Ariad Gets First Foreign Patents in Europe, Japan

Jun 16, 2000
Premium

CAMBRIDGE, Mass.--Ariad Pharmaceuticals has been granted its first foreign patents--in Europe and Japan. They cover novel genes that encode for proteins that bind to Ariad’s small-molecule drugs and control cellular activity through regulated gene transcription and protein secretion.

Filed under

Informatics
Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.